OraSure director granted 46,106 restricted shares

Kenny John P. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/05/2026 - 04:01 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Kenny John P. reported acquisition or exercise transactions in this Form 4 filing.

OraSure Technologies director John P. Kenny received a grant of 46,106 shares of Common Stock as a stock award. The grant was made at a price of $0.00 per share, increasing his direct holdings to 209,714 shares after the transaction.

According to the award terms, these restricted shares will vest in full on the earlier of June 3, 2027 or immediately before the start of the company’s 2027 Annual Meeting of Stockholders. Vesting will stop immediately if he voluntarily leaves the Board before that time.

Insider Trade Summary

Grant/Award: 46,106 shares

Grant/Award 1 txn

Insider Kenny John P.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	46,106	$0.00	$0.00

Holdings After Transaction: Common Stock — 209,714 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) June 3, 2027, or (ii) immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

Key Figures

Restricted share grant: 46,106 shares Grant price: $0.00 per share Holdings after grant: 209,714 shares +1 more

4 metrics

Restricted share grant 46,106 shares Common Stock award on June 3, 2026

Grant price $0.00 per share Equity award, not open-market purchase

Holdings after grant 209,714 shares Total direct Common Stock owned post-transaction

Vesting date June 3, 2027 Full vesting or earlier immediately before 2027 annual meeting

Key Terms

restricted shares, Stock Award Plan, vest in full, Annual Meeting of Stockholders

4 terms

restricted shares financial

"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Stock Award Plan financial

"Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan"

A stock award plan is a company program that gives employees, executives or board members shares or the right to shares as part of their pay, usually becoming theirs over time or when certain goals are met. Investors care because these awards can change how many shares exist (dilution), signal how management is being motivated, and affect future earnings per share—think of it as paying staff with future slices of the company’s pie to align incentives.

vest in full financial

"which shall vest in full upon the earlier of (i) June 3, 2027"

Annual Meeting of Stockholders financial

"immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OraSure Technologies (OSUR) report for John P. Kenny?

OraSure Technologies reported that director John P. Kenny received a grant of 46,106 shares of Common Stock. The shares were awarded at $0.00 per share, reflecting an equity-based compensation grant rather than an open-market purchase or sale.

How many OraSure (OSUR) shares does John P. Kenny hold after this Form 4 grant?

After the grant, John P. Kenny directly holds 209,714 shares of OraSure Common Stock. This total includes the newly awarded 46,106 restricted shares, as disclosed in the Form 4 insider filing for the non-derivative stock transaction.

When do John P. Kenny’s new OraSure (OSUR) restricted shares vest?

The 46,106 restricted shares vest in full on the earlier of June 3, 2027, or immediately before OraSure’s 2027 Annual Meeting of Stockholders. This schedule ties vesting to either a fixed date or the timing of that future shareholder meeting.

What conditions could affect vesting of John P. Kenny’s OraSure (OSUR) restricted shares?

Vesting stops immediately if John P. Kenny voluntarily ceases to serve on OraSure’s Board of Directors. This means continued board service is required for the restricted shares to vest as scheduled under the company’s Stock Award Plan.

Was cash paid for the restricted shares granted to John P. Kenny at OraSure (OSUR)?

No cash was paid for this grant; the transaction price per share was disclosed as $0.00. The 46,106 shares were awarded under OraSure Technologies’ Stock Award Plan as equity compensation rather than a purchase on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kenny John P.

(Last) (First) (Middle)

C/O ORASURE TECHNOLOGIES, INC.

220 EAST FIRST STREET

(Street)

BETHLEHEM PENNSYLVANIA 18015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A(1)		46,106	A	$0	209,714	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, which shall vest in full upon the earlier of (i) June 3, 2027, or (ii) immediately prior to the commencement of the Company's 2027 Annual Meeting of Stockholders. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors.

	/s/ Michele Anthony, Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)